CXCL9 and cancer: As reported in Figure 2, the serum concentration of CXCL9 was higher in cancer patients (mean: 851, min: 121, max: 3941 pg ml−1) compared with normal volunteers (mean: 635, min: 12, max: 4327 pg ml−1) (P=0.013).